The US Food and Drug Administration (FDA) has approved Edgemont Pharmaceuticals' new drug application (NDA) for Fluoxetine Tablets 60 mg.
Subscribe to our email newsletter
Edgemont’s Fluoxetine 60 mg tablet is a single pill which is used to treat major depressive disorder, obsessive compulsive disorder in adults and pediatrics, and bulimia nervosa and panic disorder in adults.
The tablets also have a functional score to allow for a convenient half-tablet 30 mg dosing option.
Edgemont president and CEO Douglas Saltel said by reducing the number of pills per dose from three pills to one, they are hopeful that their Fluoxetine 60 mg tablets may help patients be more therapy compliant.
"This is an especially important goal for the higher milligram dose patients that may be having trouble controlling their symptoms of depression," Saltel said.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.